Yael Mansour is a bold voice for increasing access to medicine and advancing innovation policy in Canada. She brings legal expertise, policy insight, and principled conviction to some of the most complex issues shaping the life sciences and health landscape.

Yael advocates for policies that strengthen Canada’s life sciences landscape, protect innovation and increase timely access to new medicines. Timely access to new medicines improves health outcomes, reduces healthcare costs, and makes Canada a more attractive investment destination, benefitting both industry and Canadians alike.

Yael contributes to national conversations on how Canada can build a more competitive, sustainable, and patient-centered life sciences landscape.  Her passion for this work is personal — shaped by her father’s experience with a rare cancer and her advocacy throughout his treatment —driving her commitment to ensuring that innovation advances and access to therapies expands for the people who need them most.